イスラエルで最高の濾胞性リンパ腫医師 - トップ21名の医師

, India

Dr. K.K. Iswaran is a reputed and experienced Obstetrician and Gynaecologist with more than 25 years of experience in his field. His key takeaways include:

• Special Interests: Obstetrics & Gynaecology Reproduction Medicine
• Treatments: IUI - Intrauterine Insemination, Ovulation Induction Procedure, Ovarian Drilling (Multiperforation), Urethral Valves
• Education: Fellowship, Ronald O Perelman and Claudia Cohen Centre, Diploma, Ireland, MBBS, University of Mysore, India

ロン・ラム医師は、内科、血液学、医療腫瘍学の認定医です。彼のプロフェッショナルな旅は、ニューヨーク州立大学ブルックリン校でのレジデンシーと、ニューヨーク医科大学ウェストチェスター医療センターでの血液学と腫瘍学のフェローシップを含みます。医学分野への彼の献身は、30以上の科学論文と医学教科書の1章を含む広範な学術的貢献を通じて示されています。さらに、彼は数百件の幹細胞移植を行い、この分野での彼の専門性を強調しています。

教育

• ニューヨーク州立大学ブルックリン校でのレジデンシー。
• ニューヨーク医科大学ウェストチェスター医療センターでの血液学と腫瘍学のフェローシップ。

プロフェッショナル経験

• 30以上の科学論文を発表し、医学教科書の1章に寄稿。
• 多数の幹細胞移植を実施。

Ronit El Hasid is the Head of Pediatric Oncohematology and Oncology at Dana Dwek Children's Hospital. She specializes in bone marrow and umbilical blood transplantation for pediatric patients. Dr. El Hasid has conducted over 300 successful transplantations. This volume of procedures provides her with deep clinical insight into complex hematologic cases.

Specialization and Pediatric Care

The doctor treats children with blood disorders and various forms of pediatric cancer. She uses high-precision procedures and therapies to improve patient outcomes. Her clinical focus includes:

• Autologous and allogenic bone marrow transplantation
• Haploidentical stem cell transplantation
• Umbilical blood transplantation
• CAR T-cell therapy and immunotherapy with Keytruda
• Intraarterial chemotherapy for specialized tumors

Conditions Treated

Dr. El Hasid treats a wide range of hematologic and oncologic conditions, including:

• Leukemia and acute lymphoblastic leukemia
• Lymphoma, including Hodgkin's, Non-Hodgkin's, and Burkitt's lymphoma
• Multiple myeloma and aplastic anemia
• Solid tumors such as neuroblastoma, retinoblastoma, and Wilms tumor
• Ewing's sarcoma and rhabdomyosarcoma
• Thrombocytopenia and other blood-related disorders

Professional Background

Dr. El Hasid leads the Department of Pediatric Oncohematology and Oncology at Dana Dwek Children's Hospital. This facility is part of the Sourasky Medical Center (Ichilov) in Tel Aviv. She gained international experience through practice at the City of Hope Hospital in Los Angeles. Additionally, she serves at various medical centers across Israel.

Academic Contributions and Research

The doctor contributes to the medical community through research and speaking engagements. Her academic record includes:

• Completion of 50 scientific publications in medical journals
• Presentation of 40 reports at international medical conferences
• Research into pediatric transplantation techniques

Professional Memberships

She stays connected to clinical advancements through several professional organizations:

• American Association for Hematology
• Israeli Society for Pediatric Hematooncology

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Michael Shapira is an experienced Bone Marrow Transplantation specialist, who speaks English and Hebrew, and graduated from the Hebrew university medical school in 1999.

• Specializes in Bone Marrow Transplantation
• Speaks English and Hebrew
• Graduated from Hebrew university medical school in 1999
• Specialized in internal medicine in Hadassah medical center
• Joined Bone Marrow Transplantation department in Hadassah as a senior physician

Dr. Fredi Aviv is an experienced Oncohematologist with 31 years of practice at the Sourasky Medical Center (Ichilov Clinic). Here are the key takeaways about him:

• 31 years of experience
• Oncohematologist

この医師は小児血液学および腫瘍学の分野での第一人者であり、特に小児の血液疾患および骨癌（肉腫）に特化しています。現在、この医師はテルアビブのSourasky Medical Centerの小児血液腫瘍科のディレクターを務め、Dana Children's Hospitalの上級小児科医でもあります。この医師は骨癌および軟部組織肉腫の治療を調整し、血液凝固障害を管理し、早産児の血液学を監督しています。この医師はイスラエル小児血液腫瘍学会（ISPHO）のメンバーです。

この医師はベングリオン大学を卒業し、Kaplan Medical Centerで小児医学を専門とし、Schneider Children's Medical Centerで小児血液学および腫瘍学をさらに専門としました。追加のトレーニングはイタリアのRizzoli Orthopaedic Instituteで骨および軟部組織の腫瘍学において完了しました。

Dr. Ilia Kirshner is a physician in hematology and medical oncology at Sourasky Medical Center. He participated in the phase III clinical trial for castrate-resistant prostate cancer treatment. This research compared the efficacy of enzalutamide against combined abiraterone therapy.

Specialization & Clinical Focus

Dr. Kirshner treats blood disorders and cancers at Sourasky Medical Center. He treats malignant conditions and bone marrow diseases. Furthermore, he provides consultations for patients with chronic and acute hematologic issues.

The doctor treats several specific conditions:

• Myeloma — a type of blood cancer that develops in plasma cells in the bone marrow
• Thrombocytopenia — a condition characterized by low blood platelet counts which can cause bruising and bleeding
• Aplastic anemia — a rare condition where the body stops producing enough new blood cells
• Follicular lymphoma — a type of slow-growing non-Hodgkin lymphoma that affects white blood cells

Education & Training

Dr. Kirshner completed medical training at several institutions in the United States.

• 1995 – Fellowship in hematology, Montefiore Medical Center
• 1994 – Fellowship in medical oncology, Montefiore Medical Center
• 1990 – Residency in internal medicine, St. Luke's-Roosevelt Hospital Center
• 1987 – Doctor of Medicine, University of Medicine and Dentistry of New Jersey
• 1983 – Bachelor of Arts, Brandeis University

Research Contributions

The physician participates in oncology research and clinical trials. He investigates pharmaceutical protocols for advanced prostate cancer. This work helps develop hormonal therapy combinations. He also focuses on survival outcomes for patients with treatment-resistant tumors.

ヤイル博士は血液学の分野、特に慢性リンパ性白血病の治療と研究に重要な貢献をしました。彼の業績は、多くの賞と発表された研究論文によって認められています。

受賞歴

• 若手研究者賞、テルアビブ・ソウラスキー医療センター医学部門（2004年）
• 臨床優秀賞、テルアビブ・ソウラスキー医療センター（2006年）
• イスラエルがん対策機構賞（2006年）
• イスラエル医師会グラント、バルーフ・ガリ教授への賛辞として（2006年）
• 医療教育と研究のためのハリー・ベラ・ウェクスナー奨学金、レガシー・ヘリテージ基金（2007年）
• クリツバーグ・オンコロジー賞、アメリカ医師フェローシップ、イスラエル医療のために（2007年）
• アメリカ血液学会トラベル賞（2008年）
• テルアビブ・ソウラスキー医療センター優秀賞（2009年）
• ワイツマン研究所-TASMC協力グラント（2010年）
• イスラエル科学財団グラント（モラシャプロジェクト）（2011年）

所属

• イスラエル血液学協会
• アメリカ血液学協会

学歴

• 医学部、ベン・グリオン大学、ベエル・シェバ、イスラエル（1989年-1995年）
• 内科レジデンシー、ラビン・メディカル・センター（1997年-1998年）
• 内科レジデンシー、メイル・メディカル・センター（1998年-2001年）
• 血液学レジデンシー、テルアビブ医学センター血液学部門（2001年-2004年）

Dr. Polina Stepensky is an expert in saving the lives of children, performing over 3,500 bone marrow transplants and being recognized by Forbes as one of the best doctors in 2018. Here are her key takeaways:

• 20 years of practice
• Perform over 3,500 bone marrow transplants
• Parents of children with rare blood cancer diseases turn to her
• Patients among themselves call her the one who "transplants life"
• Recognized by Forbes as one of the best doctors in 2018

Oncohematologist

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Professor. Hematology and Transplantology Specialist

Specialist in the hematology. Specializes in the treatment of lymphomas.